Status:

COMPLETED

PocDoc Lipids Usability Study for Self-test Use

Lead Sponsor:

Vital Signs Solutions Ltd

Conditions:

Hyperlipidemias

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study seeks to expand the approved indication of use for a UKCA approved IVD device. PocDoc lipids is approved for professional use to measure the levels of lipids in a fingerprick blood samples....

Eligibility Criteria

Inclusion

  • Signed informed consent form
  • Subjects are legally competent and capable to understand character, meaning and consequences of the study
  • Subjects own an approved mobile device (these will be available at the time of the study on the PocDoc website and a link will be contained in the PIS)

Exclusion

  • Being unable to give informed consent
  • \< 18 years or \> 85 years
  • Legally incompetent
  • Language barriers potentially compromising an adequate compliance with study procedures

Key Trial Info

Start Date :

April 26 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2023

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06053788

Start Date

April 26 2023

End Date

September 1 2023

Last Update

September 26 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Vital Signs Solutions Ltd

Cambridge, United Kingdom

PocDoc Lipids Usability Study for Self-test Use | DecenTrialz